MUC5AC and prostate carcinoma: Alternatively, the lack of type I based Lewis a (Lea) and Lewis b (Leb) antigens has been reported in prostatic carcinoma [34] and is in agreement with model predictions for the absence of Lea and Leb epitopes (Figure 4 and 6).